Broader adoption of MUSE strengthens Medigus' growth potential in Europe following completion of several procedures in leading healthcare institutions Medigus Ltd. (TASE: MDGS), a medical device ...
OMER, ISRAEL--(Marketwired - Mar 14, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
Please provide your email address to receive an email when new articles are posted on . The first Medigus Ultrasonic Surgical Endostapler, or MUSE procedures, for the treatment of gastroesophageal ...
OMER, Israel, and MARBELLA, Spain, April 17, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator ...
The successful procedure, performed by Golden Grand and broadcasted live on Chinese TV, will support the Company’s campaign to obtain additional licensing and sale agreements world-wide. Golden Grand ...
JACKSONVILLE, Fla – GERD or gastroesophageal reflux disease affects 60 percent of the adult population in the U-S. Many times the symptoms can be tamed with medicine or adjusting your diet but in some ...
OMER, ISRAEL--(Marketwired - Feb 16, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
Gastroenterologists Glen Lehman, MD, and William Kessler, MD, performed the first live Medigus Ultrasonic Surgical Endostapler procedure in the United States at Winthrop-University Hospital in Mineola ...
Professor Pier Alberto Testoni, director of gastroenterology and digestive endoscopy IRCCS at San Raffaele Hospital in Milan, Italy, has performed three MUSE procedures for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results